全文获取类型
收费全文 | 2658篇 |
免费 | 238篇 |
国内免费 | 137篇 |
专业分类
耳鼻咽喉 | 42篇 |
儿科学 | 43篇 |
妇产科学 | 37篇 |
基础医学 | 344篇 |
口腔科学 | 67篇 |
临床医学 | 287篇 |
内科学 | 458篇 |
皮肤病学 | 16篇 |
神经病学 | 120篇 |
特种医学 | 68篇 |
外科学 | 334篇 |
综合类 | 327篇 |
现状与发展 | 1篇 |
预防医学 | 126篇 |
眼科学 | 31篇 |
药学 | 290篇 |
7篇 | |
中国医学 | 228篇 |
肿瘤学 | 207篇 |
出版年
2024年 | 14篇 |
2023年 | 47篇 |
2022年 | 120篇 |
2021年 | 126篇 |
2020年 | 91篇 |
2019年 | 81篇 |
2018年 | 89篇 |
2017年 | 103篇 |
2016年 | 78篇 |
2015年 | 105篇 |
2014年 | 140篇 |
2013年 | 120篇 |
2012年 | 185篇 |
2011年 | 208篇 |
2010年 | 117篇 |
2009年 | 104篇 |
2008年 | 143篇 |
2007年 | 125篇 |
2006年 | 118篇 |
2005年 | 127篇 |
2004年 | 91篇 |
2003年 | 85篇 |
2002年 | 82篇 |
2001年 | 45篇 |
2000年 | 68篇 |
1999年 | 47篇 |
1998年 | 28篇 |
1997年 | 39篇 |
1996年 | 34篇 |
1995年 | 38篇 |
1994年 | 24篇 |
1993年 | 13篇 |
1992年 | 32篇 |
1991年 | 28篇 |
1990年 | 28篇 |
1989年 | 25篇 |
1988年 | 21篇 |
1987年 | 14篇 |
1986年 | 8篇 |
1985年 | 3篇 |
1984年 | 9篇 |
1983年 | 10篇 |
1982年 | 3篇 |
1981年 | 2篇 |
1979年 | 5篇 |
1977年 | 2篇 |
1976年 | 1篇 |
1974年 | 1篇 |
1972年 | 4篇 |
1933年 | 1篇 |
排序方式: 共有3033条查询结果,搜索用时 15 毫秒
1.
Jiang Guoxiang Zhang Ruihua Yang Xuan Zhang Wen Hou Yubin 《Clinical and experimental medicine》2022,22(2):193-200
Clinical and Experimental Medicine - Colon cancer is one of most common cancers. The progression of various cancers is driven by miRNA-570. The role of miRNA-570 in the progression of colon cancer... 相似文献
2.
3.
5.
Yubin Miao Said D Figueroa Darrell R Fisher Herbert A Moore Richard F Testa Timothy J Hoffman Thomas P Quinn 《Journal of nuclear medicine》2008,49(5):823-829
Peptide-targeted alpha-therapy with 7.4 MBq of (212)Pb-[1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid]-ReO-[Cys(3,4,10),d-Phe(7),Arg(11)]alpha-MSH(3-13) ((212)Pb-DOTA-Re(Arg(11))CCMSH) cured 45% of B16/F1 murine melanoma-bearing C57 mice in a 120-d study, highlighting its melanoma treatment potential. However, there is a need to develop an imaging surrogate for patient-specific dosimetry and to monitor the tumor response to (212)Pb-DOTA-Re(Arg(11))CCMSH therapy. The purpose of this study was to evaluate the potential of (203)Pb-DOTA-Re(Arg(11))CCMSH as a matched-pair SPECT agent for (212)Pb-DOTA-Re(Arg(11))CCMSH. METHODS: DOTA-Re(Arg(11))CCMSH was labeled with (203)Pb in 0.5 M NH(4)OAc buffer at pH 5.4. The internalization and efflux of (203)Pb-DOTA-Re(Arg(11))CCMSH were determined in B16/F1 melanoma cells. The pharmacokinetics of (203)Pb-DOTA-Re(Arg(11))CCMSH was examined in B16/F1 melanoma-bearing C57 mice. A micro-SPECT/CT study was performed with (203)Pb-DOTA-Re(Arg(11))CCMSH in a B16/F1 melanoma-bearing C57 mouse at 2 h after injection. RESULTS: (203)Pb-DOTA-Re(Arg(11))CCMSH was easily prepared in NH(4)OAc buffer and completely separated from the excess nonradiolabeled peptide by reversed-phase high-performance liquid chromatography (RP-HPLC). (203)Pb-DOTA-Re(Arg(11))CCMSH displayed fast internalization and extended retention in B16/F1 cells. Approximately 73% of (203)Pb-DOTA-Re(Arg(11))CCMSH activity internalized after a 20-min incubation at 25 degrees C. After incubation of the cells in culture medium for 20 min, 78% of internalized activity remained in the cells. (203)Pb-DOTA-Re(Arg(11))CCMSH exhibited a biodistribution pattern similar to that of (212)Pb-DOTA-Re(Arg(11))CCMSH in B16/F1 melanoma-bearing mice. (203)Pb-DOTA-Re(Arg(11))CCMSH exhibited a peak tumor uptake of 12.00+/-3.20 percentage injected dose per gram (%ID/g) at 1 h after injection. The tumor uptake gradually decreased to 3.43+/-1.12 %ID/g at 48 h after injection. (203)Pb-DOTA-Re(Arg(11))CCMSH exhibited a peak tumor-to-kidney uptake ratio of 1.53 at 2 h after injection. The absorbed doses to the tumor and kidneys were 4.32 and 4.35 Gy, respectively, per 37 MBq. Whole-body clearance of (203)Pb-DOTA-Re(Arg(11))CCMSH was fast, with approximately 89% of the injected activity cleared through the urinary system by 2 h after injection. (203)Pb showed 1.6-mm SPECT resolution, which was comparable to (99m)Tc. Melanoma lesions were visualized through SPECT/CT images of (203)Pb-DOTA-Re(Arg(11))CCMSH at 2 h after injection. CONCLUSION: (203)Pb-DOTA-Re(Arg(11))CCMSH exhibited favorable pharmacokinetic and tumor imaging properties, highlighting its potential as a matched-pair SPECT agent for (212)Pb-DOTA-Re(Arg(11))CCMSH melanoma treatment. 相似文献
6.
H Ikenaga T Ogihara S Iyori S Kou H Yoshikawa M M Okura 《Postgraduate medical journal》1989,65(768):761-764
A case of a young Japanese woman with long-standing ulcerative colitis complicated by preinfarction angina due to Takayasu's aortitis is presented. Successful emergency aorto-coronary bypass operation was performed. Whether the association of these two diseases can be explained by a common mechanism is discussed. 相似文献
7.
8.
根据热分析谱图峰顶的数学特征与Coats-Redfern方程,推得在一定实验条件下,在系列相关反应中,若峰顶温度相接近,则各反应的表观活化能E与指前因子A之间存在着有动力学意义的补偿效应,即lnA=aE+b。并经系列含水硫酸盐脱水反应实验验证。 相似文献
9.
血管腔内支架成形术治疗下肢动脉硬化闭塞症45例 总被引:10,自引:0,他引:10
目的探讨血管腔内支架成形术治疗下肢动脉硬化闭塞症的疗效。方法采用经皮穿刺股动脉或切开动脉直视下穿刺,造影明确病变动脉部位及病变长度后,利用导丝或超声消融导管开通闭塞段,球囊导管行扩张成形后置入血管内支架。结果45例(53条患肢)血管腔内支架均释放成功,踝肱指数由0.36±0.14增至术后7 d 0.77±0.21(t=2.397,P=0.021),45例随访6~54个月,平均23个月,一期肢体通畅率90.6%(48/53)。结论血管腔内支架成形术操作简便、微创、安全是治疗下肢动脉硬化闭塞症的有效方法。 相似文献
10.
对猪胰脏中提取胰酶的多种条件进行了详细研究。在本文条件下,胰蛋白酶、胰脂肪酶、胰淀粉酶三酶活力分别达4200u/g,3600u/g,5000u/g以上,收率10-13%。 相似文献